ID

36613

Description

Study ID: 105910 Clinical Study ID: 105910 Study Title: Compare Immunogenicity & Reactogenicity of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine (New vs Current) Given in Healthy Infants. The DTPa-HBV-IPV Vaccine (New Formulation) Will Also be Assessed in a 3rd Group of Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00320463 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: DTPa-HBV-IPV/Hib vaccine Trade Name: N/A Study Indication: Diphtheria, Hepatitis B, Poliomyelitis, Tetanus, Whooping Cough

Keywords

Versions (1)
  1. 5/26/19 5/26/19 -
Copyright Holder

GlaxoSmithKline

Uploaded on

May 26, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants; NCT00320463

English

Concomitant Vaccination

1 forms  
Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject Number
Description

Clinical Trial Subject Unique Identifier

Data type

integer

Alias
UMLS CUI [1]
C2348585
Concomitant Vaccination
Description

Concomitant Vaccination

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0042196
Has any vaccine other than the study vaccine(s) been administered during the timeframe as specified in the Protocol?
Description

Concomitant Agent, Vaccination

Data type

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0042196
Trade / (Generic) Name
Description

Concomitant Agent, Vaccination, Medication name

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0042196
UMLS CUI [1,3]
C2360065
Route
Description

Concomitant Agent, Vaccination, Drug Administration Routes

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0042196
UMLS CUI [1,3]
C0013153
Administration date
Description

Concomitant Agent, Vaccination, Date in time

Data type

date

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0042196
UMLS CUI [1,3]
C0011008
Back to the top of the page

Similar models

Concomitant Vaccination

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Clinical Trial Subject Unique Identifier
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Item Group
Concomitant Vaccination
C2347852 (UMLS CUI-1)
C0042196 (UMLS CUI-2)
Concomitant Agent, Vaccination
Item
Has any vaccine other than the study vaccine(s) been administered during the timeframe as specified in the Protocol?
boolean
C2347852 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
Concomitant Agent, Vaccination, Medication name
Item
Trade / (Generic) Name
text
C2347852 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
C2360065 (UMLS CUI [1,3])
Concomitant Agent, Vaccination, Drug Administration Routes
Item
Route
text
C2347852 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
C0013153 (UMLS CUI [1,3])
Concomitant Agent, Vaccination, Date in time
Item
Administration date
date
C2347852 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial